Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
2.455 USD | +9.60% | -3.36% | +10.63% |
08/05 | Transcript : Standard BioTools Inc., Q1 2024 Earnings Call, May 08, 2024 | |
08/05 | Earnings Flash (LAB) STANDARD BIOTOOLS Reports Q1 Revenue $45.5M, vs. Street Est of $46M | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+10.63% | 857M | |
+8.63% | 219B | |
+8.21% | 185B | |
+14.33% | 135B | |
+27.73% | 107B | |
+14.70% | 51.28B | |
+4.48% | 51.01B | |
+3.96% | 41.85B | |
+6.12% | 37.02B | |
+26.07% | 31.27B |
- Stock Market
- Equities
- LAB Stock
- News Standard BioTools Inc.
- KeyBanc Initiates Standard BioTools at Overweight With $4 Price Target, Sees 'Attractively Valued Way to Invest' in Life Sciences Technology